Search Results - "Agosti, V."

Refine Results
  1. 1
  2. 2

    Subthreshold depression and subjective cognitive complaints in Parkinson's disease by Santangelo, G., Vitale, C., Trojano, L., Angrisano, M. G., Picillo, M., Errico, D., Agosti, V., Grossi, D., Barone, P.

    Published in European journal of neurology (01-03-2014)
    “…Background and purpose Subthreshold depression (SubD) is characterized by clinically relevant depressive symptoms not meeting criteria for major depression…”
    Get full text
    Journal Article
  3. 3

    Sgk1 enhances RANBP1 transcript levels and decreases taxol sensitivity in RKO colon carcinoma cells by Amato, R, Scumaci, D, D'Antona, L, Iuliano, R, Menniti, M, Di Sanzo, M, Faniello, M C, Colao, E, Malatesta, P, Zingone, A, Agosti, V, Costanzo, F S, Mileo, A M, Paggi, M G, Lang, F, Cuda, G, Lavia, P, Perrotti, N

    Published in Oncogene (19-09-2013)
    “…The serum- and glucocorticoid-regulated kinase (Sgk1) is essential for hormonal regulation of epithelial sodium channel-mediated sodium transport and is…”
    Get full text
    Journal Article
  4. 4

    Biological mechanisms of stroke prevention by physical activity in type 2 diabetes by Agosti, V., Graziano, S., Artiaco, L., Sorrentino, G.

    Published in Acta neurologica Scandinavica (01-04-2009)
    “…The principal modifiable risk factors for stroke are hypertension, diabetes mellitus, hypercholesterolaemia, hyperhomocysteinaemia, smoking and limited…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Patient factors related to early attrition from an outpatient cocaine research clinic by Agosti, V, Nunes, E, Ocepeck-Welikson, K

    “…The dropout rates among cocaine abusers in outpatient treatment programs have averaged 55%. We sought to find patient predictor variables associated with early…”
    Get more information
    Journal Article
  7. 7

    Somatization as a predictor of medication discontinuation due to adverse events by Agosti, V, Quitkin, F.M, Stewart, J.W, McGrath, P.J

    Published in International clinical psychopharmacology (01-11-2002)
    “…Medication discontinuation due to intolerable side-effects remains a significant clinical problem in the treatment of depression. We were unable to locate…”
    Get full text
    Journal Article
  8. 8

    A 5′ Regulatory Sequence Containing Two Ets Motifs Controls the Expression of the Wiskott-Aldrich Syndrome Protein (WASP) Gene in Human Hematopoietic Cells by Petrella, A., Doti, I., Agosti, V., Giarrusso, P. Carandente, Vitale, D., Bond, H.M., Cuomo, C., Tassone, P., Franco, B., Ballabio, A., Venuta, S., Morrone, G.

    Published in Blood (15-06-1998)
    “…The recently-identified Wiskott-Aldrich syndrome protein gene (WASP) is responsible for the Wiskott-Aldrich X-linked immunodeficiency as well as for isolated…”
    Get full text
    Journal Article
  9. 9

    Inhibition of the differentiation of human myeloid cell lines by redox changes induced through glutathione depletion by ESPOSITO, F, AGOSTI, V, MORRONE, G, MORRA, F, CUOMO, C, RUSSO, T, VENUTA, S, CIMINO, F

    Published in Biochemical journal (01-08-1994)
    “…We have investigated the effect of redox changes in vivo on the differentiation of two human myeloid cell lines, HL-60 and KG-1. The glutathione-depleting…”
    Get full text
    Journal Article
  10. 10

    Placebo run-in period in studies of depressive disorders. Clinical, heuristic and research implications by Quitkin, F M, McGrath, P J, Stewart, J W, Ocepek-Welikson, K, Taylor, B P, Nunes, E, Delivannides, D, Agosti, V, Donovan, S J, Ross, D, Petkova, E, Klein, D F

    Published in British journal of psychiatry (01-09-1998)
    “…In spite of the virtually ubiquitous nature of the initial 10-day placebo run-in period (IPR) in drug trials, there is little empirical data establishing its…”
    Get more information
    Journal Article
  11. 11

    Need for recovery amongst emergency physicians in the UK and Ireland: a cross-sectional survey by Cottey, Laura, Lyttle, Mark David, Latour, Jos, Kane, L, Richter, S, Selway, J, Rimmer, C, Ayres, M, Kaur, K, Hartshorn, S, McGregor, K, Gardner, G, Clingo, T, Stewart, R, Mullen, N, Mirza, K, Cuthbert, P, Veeramuthu, K, Lipton, G, Umana, E, Agosti, V, Kerr, J, Dhutia, SJ, Cherian, B, Williams, O, Lindsay, C, Manou, S, Nunn, C, Fuller, R, Reynard, C, Daly, J, Boggaram, G, McConnell, D, Hirst, R, Muller, J, Chatha, H, Ramsundar, S, Sparkes, T, Barrett, L, Driessen, J, Meredith, S, Grimsmo-Powney, H, Malik, H, Gwatkin, L, Blackburn, R, Gillies, F, McLoughlin, TF, Hopping, K, Challen, K, Macdonald, M, Randle, A, Fairbairn, H, Thompson, J, Gray, S, Foley, J, Gardner, S, Pintus, S, Brammer, K, Raghunathan, A, Langston, S, Cooper, H, Arumugam, A, Moulds, Y, Thom, DL, Ali, N, Mackay, A, Frost, E, Wright, R, Saunders, A, Malik, KI, Fatkin, A, Naeem, S, Basu, A, Hill, O, Boulind, C, Williams, P, Hardwick, S, Gandolfi, C, Everitt, E, Ghosh, A, McKeever, D, Savage, L, Bailey, S, Sharr, R, Loffhagen, R, Rivers, V, Khan, HD, Baird, H, Bury, S, Gaiawyn, J, Johnson, G, Akhtar, A, Clarke, B, Colmar, M, Morrison, M, Raffo, D, Griffiths, OR, McIlwham, B, Cunningham, K, Clegg, E

    Published in BMJ open (02-11-2020)
    “…ObjectivesTo determine the need for recovery (NFR) among emergency physicians and to identify demographic and occupational characteristics associated with…”
    Get full text
    Journal Article
  12. 12

    Identification by Differential Display of Transcripts Regulated during Hematopoietic Differentiation by Bond, H. M., Bonelli, P., Mesuraca, M., Agosti, V., Masone, C., Cuomo, C., Nisticò, A., Tassone, P., Tuccillo, F., Cecco, L., Iacopino, L., Barbieri, V., Cerra, M., Costanzo, F. S., Morrone, G., Venuta, S.

    Published in Stem cells (Dayton, Ohio) (01-01-1998)
    “…The polymerase chain reaction‐based differential display method (DDRT‐PCR) was used to identify mRNAs differentially expressed during the maturation of human…”
    Get full text
    Journal Article
  13. 13

    Regulation of cell survival in CD95-induced T cell apoptosis: role of NF-kappa B/Rel transcription factors by Lamberti, A, Romano, M F, Agosti, V, Garbi, C, Sun, S C, Bond, H M, Bonelli, P, Turco, M C, Venuta, S

    Published in Apoptosis (London) (01-06-1999)
    “…The activity of NF-kappa B/Rel transcription factors can inhibit the apoptosis induced by TNF, UV or cancer therapy drugs in a number of cell types, including…”
    Get full text
    Journal Article
  14. 14

    Gastrointestinal Stromal Tumors in a Mouse Model by Targeted Mutation of the Kit Receptor Tyrosine Kinase by Sommer, Gunhild, Agosti, Valter, Ehlers, Imke, Rossi, Ferdinand, Corbacioglu, Selim, Farkas, Judith, Moore, Malcolm, Manova, Katia, Antonescu, Cristina R., Besmer, Peter

    “…Oncogenic Kit mutations are found in somatic gastrointestinal (GI) stromal tumors (GISTs) and mastocytosis. A mouse model for the study of constitutive…”
    Get full text
    Journal Article
  15. 15

    Subthreshold depression and subjective cognitive complaints in P arkinson's disease by Santangelo, G., Vitale, C., Trojano, L., Angrisano, M. G., Picillo, M., Errico, D., Agosti, V., Grossi, D., Barone, P.

    Published in European journal of neurology (01-03-2014)
    “…Background and purpose Subthreshold depression (Sub D ) is characterized by clinically relevant depressive symptoms not meeting criteria for major depression…”
    Get full text
    Journal Article
  16. 16

    Differential regulation of the expression of interleukin-2 receptor gamma-chain during the in vitro differentiation of human myeloid cells by Morrone, G, Bond, H M, Cuomo, C, Agosti, V, Petrella, A, Pagnano, A M, Della Corte, A, Marasco, O, Venuta, S

    Published in Biochemical journal (15-06-1995)
    “…The common gamma-chain (gamma c) is a shared component of cell-surface receptors for the interleukins- 2, -4 and -7, and possibly others. We studied its…”
    Get full text
    Journal Article
  17. 17

    Efficacy and safety of antidepressant monotherapy in the treatment of bipolar-II depression by Agosti, Vito, Stewart, Jonathan W

    Published in International clinical psychopharmacology (01-09-2007)
    “…Sparse data exist regarding the risks and benefits of treating bipolar-II depression with antidepressants alone. On the basis of studies of bipolar-I patients,…”
    Get full text
    Journal Article
  18. 18

    Critical role for Kit-mediated Src kinase but not PI 3-kinase signaling in pro T and pro B cell development by Agosti, Valter, Corbacioglu, Selim, Ehlers, Imke, Waskow, Claudia, Sommer, Gunhild, Berrozpe, Georgina, Kissel, Holger, Tucker, Christine M, Manova, Katia, Moore, Malcolm A S, Rodewald, Hans-Reimer, Besmer, Peter

    Published in The Journal of experimental medicine (15-03-2004)
    “…The Kit receptor functions in hematopoiesis, lymphocyte development, gastrointestinal tract motility, melanogenesis, and gametogenesis. To investigate the…”
    Get full text
    Journal Article
  19. 19

    Predictors of persistent social impairment among recovered depressed outpatients by Agosti, Vito

    Published in Journal of affective disorders (01-10-1999)
    “…Background: Though the social functioning of most depressed outpatients improves with effective treatment, a subgroup may remain impaired after recovering from…”
    Get full text
    Journal Article
  20. 20

    Atypical and non-atypical subtypes of depression: comparison of social functioning, symptoms, course of illness, co-morbidity and demographic features by Agosti, Vito, Stewart, Jonathan W

    Published in Journal of affective disorders (01-06-2001)
    “…Background: There are scant data regarding the demographic and psychosocial characteristics of outpatients with Atypical Depression (AD). Methods: The…”
    Get full text
    Journal Article